Kazia Therapeutics (KZIA) Payables (2009 - 2025)
Kazia Therapeutics (KZIA) posted Payables of $6.4 million for Q4 2025, down 4.94% on a QoQ basis from $6.7 million in Q2 2025, and down 7.68% year-over-year from $6.9 million in Q4 2024.
Kazia Therapeutics (KZIA) has 14 years of Payables data on file, last reported at $6.4 million in Q4 2025.
- In Q4 2025, Payables fell 7.68% year-over-year to $6.4 million; the TTM figure through Dec 2025 stood at $6.4 million (down 7.68% YoY), while the FY2025 annual figure was $6.7 million, down 34.94% from the prior year.
- Payables retreated to $6.4 million in Q4 2025, from $6.7 million in the prior quarter.
- Across five years, Payables topped out at $10.3 million in Q2 2024 and bottomed at $1.4 million in Q2 2022.
- A 5-year average of $5.1 million and a median of $4.1 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables sank 63.83% — and 2023, when it jumped 197.98%.
- Year by year, Payables stood at $3.8 million in 2021, then plunged by 35.99% to $2.4 million in 2022, then jumped by 69.89% to $4.1 million in 2023, then surged by 67.8% to $6.9 million in 2024, then retreated by 7.68% to $6.4 million in 2025.
- The last three Payables figures came in at $6.4 million (Q4 2025), $6.7 million (Q2 2025), and $6.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | 6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.40 Mn |
| Jun 30, 2025 | 6.73 Mn |
| Dec 31, 2024 | 6.93 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Dec 31, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.09 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Jun 30, 2021 | 3.80 Mn |
| Dec 31, 2020 | 1.84 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Jun 30, 2019 | 1.24 Mn |
| Dec 31, 2018 | 1.65 Mn |
| Jun 30, 2018 | 1.07 Mn |
| Jun 30, 2017 | 938,261.70 |
| Dec 31, 2016 | 2.09 Mn |
| Jun 30, 2016 | 1.40 Mn |
| Jun 30, 2012 | 3.71 Mn |
| Dec 31, 2011 | 4.58 Mn |
| Jun 30, 2011 | 6.78 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Jun 30, 2010 | 4.74 Mn |
| Dec 31, 2009 | 2.41 Mn |
| Jun 30, 2009 | 6.12 Mn |